10/17/2008 | SS | Tercica shareholder approval leads to merger with Ipsen
|
6/4/2008 | SS | Ipsen to acquire Tercica
|
7/10/2007 | PP | New Issue: Tercica secures $6.92 million from two stock offerings
|
11/10/2006 | BT | Market Commentary: Tanox soars 45% on Genentech buy; Targeted Genetics adds 26%, Pozen higher; Insmed, Tercica better
|
10/5/2006 | BT | Market Commentary: AnorMED up 7% as Genzyme boosts bid; GenVec gains 18%; Acorda rises; Light Sciences at bat
|
8/31/2006 | BT | Market Commentary: Genta off 15.5%; EpiCept off on PIPE; AnorMED steady; Diomed gains 28%; ImmunoGen higher
|
7/19/2006 | BT | Market Commentary: Amgen up slightly ahead of earnings; Isis, NeoPharm, Genta up; Affymetrix off, Illumina up 29%
|
7/18/2006 | BT | Ipsen, Tercica to collaborate in endocrinology
|
7/18/2006 | BT | Market Commentary: Tercica up 12%, Insmed rises 9%; Neurocrine closes weaker; Pharma Product up; New River deal emerges
|
7/7/2006 | BT | Market Commentary: LifeCell lower; CV Therapeutics loses 2%; Indevus up; Tercica off by 8%; Amarillo Biosciences off
|
7/5/2006 | BT | Market Commentary: DOV seesaws on CEO exit, closes higher; Neurocrine slides further; Insmed drops 8%; Tercica off 1%
|
7/5/2006 | BT | Market Commentary: DOV seesaws on CEO exit, closes higher; Neurocrine slides further; Insmed drops 8%; Tercica off 1%
|
7/5/2006 | BT | Court rules Insmed infringes Tercica IGF-1 process patent
|
6/28/2006 | BT | Market Commentary: Replidyne debut shaky but closes in the green; Indevus rises in face of spot sale; Depomed loses 3%
|
6/21/2006 | BT | Tercica launches Increlex patient database
|
6/14/2006 | BT | Tercica plans to target children diagnosed with ISS as possible Increlex candidates
|
5/11/2006 | BT | Updated data shows Tercica's Increlex effective in treatment of children with Primary IGFD
|
5/9/2006 | BT | Market Commentary: Hollis-Eden loses in advance of first-quarter report; Tercica dives 22% after close; Curis rises 17%
|
1/26/2006 | BT | Tercica greenshoe exercised, raising deal to $36.8 million
|
1/24/2006 | BT | Market Commentary: Nuvelo, Tercica toss hats in ring; Serono plunges on lack of suitors; Imclone results miss, seeks merger
|
1/24/2006 | BT | New Issue: Tercica raises $32 million in follow-on of 5 million shares at $6.40
|
12/13/2005 | BT | Market Commentary: CuraGen sinks; Indevus soars; Voyager pulls IPO; Insmed up on FDA approval; Tercica falls
|
10/14/2005 | PP | Market Commentary: PNM Resources completes $100 million; Tercica gets $75 million equity line from Kingsbridge
|
10/14/2005 | BTPP | New Issue: Tercica receives equity line for up to $75 million
|
9/9/2005 | BTCV | Tercica files $75 million shelf
|
8/17/2005 | BT | Market Commentary: Access in talks to dodge a forced bankruptcy; Exelixis trades down to follow-on level; Insmed seesaws
|